Corcept Therapeutics (CORT) announced that the primary endpoint was met in the treatment phase of CATALYST, a randomized, double-blind, placebo-controlled study of Korlym in patients with ...

More frequent and costly threats are driving growth at cybersecurity firms, attracting investors to these ETFs.

The best endpoint protection solutions provide a unified solution for managing your business devices and IT network, while also protecting them from cybercriminals who try to infiltrate your ...

Cisco is in the middle of an identity shift as it continues to increase recurring revenue from subscription-based software and services, while transitioning to the AI era, described by Cisco as a ...

Dell Technologies Inc. Cl C 0.29% $83.31B ...

More frequent and costly threats are driving growth at cybersecurity firms, attracting investors to these ETFs.

Download Cisco Secure Client. Double click on the Cisco Secure Client software icon. Cisco Secure Client may be subject to the U.S. Export Administration Regulations and other U.S. law, and may not be ...

Regeneron (REGN) Pharmaceuticals announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD Injection 8 mg for the treatment of patients with macular edema following ...

After hours: December 23 at 4:01:48 PM EST Loading Chart for ICON ...